Moody's affirms J&J's (JNJ) Aaa rating; raises outlook from Negative to Stable
Moody's affirms J&J's (NYSE: JNJ) Aaa rating; raises outlook from Negative to Stable
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PREZCOBIX™ (darunavir/cobicistat) Approved in the U.S. for the Treatment of Adults Living With HIV-1
- Universal (UVV) No Longer Under S&P 'Ccriteria Observation'; Normal Outlook Still Negative
- Mednax (MD) PT Raised to $80 at Jefferies
Create E-mail Alert Related CategoriesCredit Ratings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!